A statistically significant reduction in pain was observed at any time point, and quality of life measured at six months showed a nonsignificant trend toward increase.
← all excerpts
Autologous Peripheral Blood Mononuclear Cells in Patients with Small Artery Disease and Diabetic Foot Ulcers: Efficacy, Safety, and Economic Evaluation.
1
—
—